Skip to main content
TipRanks
Go Ultimate75% OFF

James Emigh Insider Profile

4 Followers

James Emigh, VP & Corp. Dev at Acura Pharmaceuticals, holds 474.04K shares in Acura Pharmaceuticals (Ticker: ACUR).

James Emigh's Trading History

ACUR
Acura Pharmaceuticals
Feb 26, 2021VP & Corp. DevUninformative Buy1.87K$4.74K
ACUR
Insider Shares: 474.04K (2.19%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 26, 2021Uninformative Buy$1.87K12,450$0.15―
Jan 06, 2020Uninformative Buy$1.31K4,667$0.28―
Dec 18, 2017Informative Buy$40.00K400,000$0.10-56.30%
May 16, 2014Informative Buy$18.00K15,000$1.20-34.80%
Jan 27, 2014Informative Buy$8.09K6,225$1.30-66.00%

You May Also Like

James Emigh insider profile FAQ

What is the percentage of profitable transactions made by James Emigh?
The percentage of profitable transactions made by James Emigh is 0%.
What is the average return per transaction made by James Emigh?
The average return per transaction made by James Emigh is -52.30%.
What stocks does James Emigh hold?
James Emigh holds: ACUR stocks.
What was James Emigh’s latest transaction?
James Emigh’s latest transaction was an Uninformative Buy of $1.87K.
What was James Emigh's most profitable transaction?
James Emigh’s most profitable transaction was an Informative Buy of ACUR stock on May 16, 2014. The return on the trade was -34.80%.
What is James Emigh's role in Acura Pharmaceuticals?
James Emigh's role in Acura Pharmaceuticals is VP & Corp. Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.